Invention Grant
- Patent Title: RORS as modifiers of the p21 pathway and methods of use
- Patent Title (中): RORS作为p21途径的修饰剂和使用方法
-
Application No.: US12325914Application Date: 2008-12-01
-
Publication No.: US08426147B2Publication Date: 2013-04-23
- Inventor: Helen Francis-Lang , Lori Friedman , Thomas Kidd , Siobhan Roche , Haiguang Zhang
- Applicant: Helen Francis-Lang , Lori Friedman , Thomas Kidd , Siobhan Roche , Haiguang Zhang
- Applicant Address: US CA South San Francisco
- Assignee: Exelixis, Inc.
- Current Assignee: Exelixis, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
Human ROR genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of ROR are provided.
Public/Granted literature
- US20090149413A1 RORS as Modifiers of the p21 Pathway and Methods of Use Public/Granted day:2009-06-11
Information query
IPC分类:
